To understand how oral nanoparticles influence the tumor microenvironment, we investigated anti-metastasis in terms of angiogenesis, EMT, and ECM remodeling via immunohistochemistry (IHC) and detection of the CD31, TGF-β1, and MMP-9 expression levels. The gene discussed is TGFB1; the disease is neoplasm.